翻訳と辞書
Words near each other
・ Glubbdubdrib
・ Glubbslyme
・ Glubochek
・ Glubokoye District
・ Gluboky
・ Gluboky, Russia
・ Glucagon
・ Glucagon receptor
・ Glucagon receptor family
・ Glucagon rescue
・ Glucagon-like peptide 1 receptor
・ Glucagon-like peptide 2 receptor
・ Glucagon-like peptide receptor
・ Glucagon-like peptide-1
・ Glucagon-like peptide-1 agonist
Glucagon-like peptide-2
・ Glucagonoma
・ Glucal
・ Glucan
・ Glucan 1,3-alpha-glucosidase
・ Glucan 1,3-beta-glucosidase
・ Glucan 1,4-a-glucosidase
・ Glucan 1,4-alpha-maltohexaosidase
・ Glucan 1,4-alpha-maltohydrolase
・ Glucan 1,4-alpha-maltotetraohydrolase
・ Glucan 1,4-alpha-maltotriohydrolase
・ Glucan 1,4-beta-glucosidase
・ Glucan 1,6-a-glucosidase
・ Glucan 1,6-alpha-isomaltosidase
・ Glucan endo-1,2-beta-glucosidase


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Glucagon-like peptide-2 : ウィキペディア英語版
Glucagon-like peptide-2
Glucagon-like peptide-2 (GLP-2) is a 33 amino acid peptide with the sequence HADGSFSDEMNTILDNLAARDFINWLIQTKITD (see Proteinogenic amino acid) in humans. GLP-2 is created by specific post-translational proteolytic cleavage of proglucagon in a process that also liberates the related glucagon-like peptide-1 (GLP-1). GLP-2 is produced by the intestinal endocrine L cell and by various neurons in the central nervous system. Intestinal GLP-2 is co-secreted along with GLP-1 upon nutrient ingestion.
When externally administered, GLP-2 produces a number of effects in humans and rodents, including intestinal growth, enhancement of intestinal function, reduction in bone breakdown and neuroprotection. GLP-2 may act in an endocrine fashion to link intestinal growth and metabolism with nutrient intake. GLP-2 and related analogs may be treatments for short bowel syndrome, Crohn's disease, osteoporosis and as adjuvant therapy during cancer chemotherapy.
==See also==

* Glucagon-like peptide 2 receptor

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Glucagon-like peptide-2」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.